Sorensen; Stephen M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sorensen; Stephen M..The latest application filed is for "use of r (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition".

Company Profile

0.5.6

Sorensen; Stephen M. - Chester NJ
Sorensen; Stephen M. - Cincinnati OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of behavioral or psychological symptoms associated with a disease Grant 7,132,433 - Scheyer , et al. November 7, 2	2006-11-07
Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition App 20050272773 - Mondadori, Cesar ; et al.	2005-12-08
Use of R (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol for the treatment of substance induced insomnia Grant 6,939,879 - Mondadori , et al. September 6, 2	2005-09-06
Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis App 20040204457 - Scheyer, Richard D. ; et al.	2004-10-14
Use of R (+)-alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders App 20040002516 - Mondadori, Cesare ; et al.	2004-01-01
Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis App 20030036553 - Scheyer, Richard D. ; et al.	2003-02-20
Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis App 20020099076 - Richard, Scheyer D. ; et al.	2002-07-25
The use of R (+)-alpha- (2,3-Dimethoxyphenyl) -1- [ 2- (4-fluorophenyl) ethyl] -4-piper idinemethanol for the treatment of sleep disorders App 20010041719 - Mondadori, Cesare ; et al.	2001-11-15
5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders Grant 5,436,252 - Sorensen , et al. July 25, 1	1995-07-25
1,4-disubstituted-piperidinyl compounds as pain relievers Grant 5,064,838 - Carr , et al. November 12, 1	1991-11-12
Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof Grant 5,011,846 - Gittos , et al. April 30, 1	1991-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.